Ligand Pharmaceuticals, Inc. (LGND)
313.73
+6.71
(+2.19%)
USD |
NASDAQ |
Nov 03, 16:00
313.73
0.00 (0.00%)
After-Hours: 16:17
Ligand Pharmaceuticals Cash and Short Term Investments (Quarterly) : 451.51M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 451.51M |
| June 30, 2026 | 1.358B |
| March 31, 2026 | 779.42M |
| December 31, 2025 | 733.52M |
| September 30, 2025 | 664.52M |
| June 30, 2025 | 245.02M |
| March 31, 2025 | 208.90M |
| December 31, 2024 | 256.16M |
| September 30, 2024 | 219.64M |
| June 30, 2024 | 226.93M |
| March 31, 2024 | 310.59M |
| December 31, 2023 | 170.31M |
| September 30, 2023 | 190.50M |
| June 30, 2023 | 219.04M |
| March 31, 2023 | 282.66M |
| December 31, 2022 | 211.87M |
| September 30, 2022 | 121.41M |
| June 30, 2022 | 147.94M |
| March 31, 2022 | 204.00M |
| December 31, 2021 | 341.11M |
| September 30, 2021 | 323.21M |
| June 30, 2021 | 301.98M |
| March 31, 2021 | 339.55M |
| December 31, 2020 | 411.53M |
| September 30, 2020 | 795.26M |
| Date | Value |
|---|---|
| June 30, 2020 | 810.61M |
| March 31, 2020 | 772.42M |
| December 31, 2019 | 1.071B |
| September 30, 2019 | 1.151B |
| June 30, 2019 | 1.394B |
| March 31, 2019 | 1.504B |
| December 31, 2018 | 767.19M |
| September 30, 2018 | 1.156B |
| June 30, 2018 | 1.017B |
| March 31, 2018 | 291.89M |
| December 31, 2017 | 201.66M |
| September 30, 2017 | 202.26M |
| June 30, 2017 | 172.63M |
| March 31, 2017 | 159.37M |
| December 31, 2016 | 141.05M |
| September 30, 2016 | 124.12M |
| June 30, 2016 | 106.95M |
| March 31, 2016 | 113.20M |
| December 31, 2015 | 200.22M |
| September 30, 2015 | 187.90M |
| June 30, 2015 | 182.21M |
| March 31, 2015 | 177.22M |
| December 31, 2014 | 167.34M |
| September 30, 2014 | 186.59M |
| June 30, 2014 | 22.03M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 17.23B |
| Eli Lilly & Co. | 4.885B |
| Merck & Co., Inc. | -- |
| Indivior Pharmaceuticals, Inc. | 305.00M |
| Bristol Myers Squibb Co. | 12.58B |